Incyte: Q4 Earnings Snapshot

SelfRugger · 2026-02-12T11:35:32+00:00

Incyte Corp. reported Q4 earnings of $299.3 million, or $1.46 per share, which fell short of analyst estimates of $1.94. However, revenue of $1.51 billion exceeded expectations. For the year, profit totaled $1.29 billion on $5.14 billion in revenue.

SelfRugger

2026-02-12 11:35:32

Abstract generation in progress

Incyte: Q4 Earnings Snapshot

Associated Press Finance

Tue, February 10, 2026 at 9:24 PM GMT+9 1 min read

In this article:

INCY

+0.59%

WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Incyte Corp. (INCY) on Tuesday reported fourth-quarter earnings of $299.3 million.

On a per-share basis, the Wilmington, Delaware-based company said it had net income of $1.46. Earnings, adjusted for one-time gains and costs, came to $1.80 per share.

The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.94 per share.

The specialty drugmaker posted revenue of $1.51 billion in the period, which topped Street forecasts. Ten analysts surveyed by Zacks expected $1.35 billion.

For the year, the company reported profit of $1.29 billion, or $6.41 per share. Revenue was reported as $5.14 billion.

This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on INCY at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.